Treatment Based on Cinacalcet Reduces Oxidative Stress in Hemodialysis Patients with Secondary Hyperparathyroidism
Conclusions: (1) Six-month treatment based on cinacalcet seems to reduce oxidative stress markers in maintenance hemodialysis patients with sHPT. (2) This benefit may be related rather to the direct action of cinacalcet than to the serum PTH concentration decrease.Nephron
Source: Nephron - Category: Urology & Nephrology Source Type: research
More News: Antidoxidants | Calcium | Chronic Kidney Disease | Dialysis | Hemodialysis | Hormones | Hyperparathyroidism | Sensipar | Study | Urology & Nephrology